Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients
Authors:
- 4 November 2010
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (10) , 1238-1240
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Efficacité du rituximab dans une pemphigoïde bulleuse en échec thérapeutiqueAnnales de Dermatologie et de Vénéréologie, 2009
- The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvementBritish Journal of Ophthalmology, 2009
- Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody RituximabActa Dermato-Venereologica, 2009
- Severe Bullous Pemphigoid in an Infant— Successful Treatment with RituximabPediatric Dermatology, 2008
- A new approach on bullous pemphigoid therapyAnnals of Oncology, 2008
- A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapyClinical and Experimental Dermatology, 2008
- Rituximab for Pemphigus VulgarisNew England Journal of Medicine, 2007
- Rituximab in autoimmune bullous diseases: mixed responses and adverse effectsBritish Journal of Dermatology, 2007
- B-cell targeted therapy alone may not be effective in bullous pemphigoidClinical and Experimental Dermatology, 2006
- Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host diseaseBone Marrow Transplantation, 2002